INS-365

INS-365 is a pharmaceutical drug that is used in the treatment of dry eye syndrome. It is a P2Y2 receptor agonist, which means it works by stimulating the P2Y2 receptors in the body. This stimulation leads to an increase in the production of tears, which can help to alleviate the symptoms of dry eye syndrome.

Mechanism of Action

INS-365 works by binding to the P2Y2 receptor, a type of purinergic receptor found in the body. These receptors are involved in a variety of physiological processes, including the regulation of tear production. By stimulating these receptors, INS-365 can increase the production of tears and help to alleviate the symptoms of dry eye syndrome.

Uses

INS-365 is primarily used in the treatment of dry eye syndrome, a condition that is characterized by a lack of sufficient lubrication and moisture on the surface of the eye. This can lead to symptoms such as irritation, redness, and a gritty or scratchy feeling in the eye. By increasing tear production, INS-365 can help to alleviate these symptoms and improve the overall health of the eye.

Side Effects

Like all medications, INS-365 can cause side effects. These can include eye irritation, blurred vision, and a burning or stinging sensation in the eye. If these side effects persist or become severe, it is recommended to consult a healthcare provider.

See Also

• P2Y2 receptor
• Dry eye syndrome
• Pharmaceutical drug

INS-365 Resources
Latest articles Most recent articles Ongoing trials	Wikipedia